Variables | Unfavorable glycemic control | ||
---|---|---|---|
OR | 95% CI | p value | |
Heart rate | 1.016 | 1.008–1.024 | < 0.001 |
Age | 0.984 | 0.976–0.992 | < 0.001 |
Male (ref: female) | 0.759 | 0.636–0.904 | 0.002 |
Stroke severity | Â | Â | Â |
Mild (eNIHSS < 5) | reference |  |  |
Moderate (eNIHSS 5–14) | 0.860 | 0.714–1.037 | 0.114 |
Severe (eNIHSS > 14) | 0.407 | 0.276–0.598 | < 0.001 |
Body mass index | 0.995 | 0.976–1.015 | 0.626 |
HTN (ref: without HTN) | 0.857 | 0.693–1.061 | 0.156 |
Dyslipidemia (ref: without dyslipidemia) | 0.942 | 0.807–1.099 | 0.448 |
AF (ref: without AF) | 0.916 | 0.705–1.190 | 0.511 |
CAD (ref: without CAD) | 1.279 | 0.986–1.660 | 0.063 |
CHF (ref: without CHF) | 1.286 | 0.893–1.853 | 0.177 |
History of cancer (ref: without history of cancer) | 0.736 | 0.525–1.031 | 0.075 |
Smoker (ref: non-smoker) | 1.200 | 1.001–1.439 | 0.048 |
Total cholesterol | 1.081 | 1.005–1.162 | 0.035 |
Triglyceride | 1.056 | 0.990–1.127 | 0.099 |
Estimated glomerular filtration rate | 1.001 | 0.999–1.004 | 0.243 |
Alanine aminotransferase | 0.998 | 0.994–1.001 | 0.123 |
Systolic blood pressure | 1.005 | 0.999–1.011 | 0.096 |
Diastolic blood pressure | 0.980 | 0.969–0.991 | 0.001 |
Beta blockers user (ref: non-user) | 0.806 | 0.635–1.024 | 0.077 |
Insulin user (ref: non-user) | 3.281 | 2.260–4.763 | < 0.001 |